CRC
EXAS

Curi RMB Capital’s Exact Sciences EXAS Stock Holding History

Curi RMB Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-111,021
Closed -$11.3M – 899
2025
Q4 		$11.3M Buy
111,021
+83,707
+306% +$6.72M 0.2% 125
2025
Q3 		$1.49M Sell
27,314
-135
-0.5% -$6.75K 0.03% 370
2025
Q2 		$1.46M Buy
27,449
+13,455
+96% +$684K 0.03% 368
2025
Q1 		$606K Sell
13,994
-10,902
-44% -$552K 0.01% 368
2024
Q4 		$1.4M Buy
24,896
+428
+2% +$26.6K 0.03% 304
2024
Q3 		$1.67M Buy
24,468
+754
+3% +$42.6K 0.04% 288
2024
Q2 		$1M Buy
23,714
+2,913
+14% +$160K 0.02% 330
2024
Q1 		$1.44M Buy
20,801
+2
+0% +$127 0.03% 308
2023
Q4 		$1.54M Sell
20,799
-11
-0.1% -$721 0.05% 257
2023
Q3 		$1.42M Sell
20,810
-836
-4% -$70.9K 0.05% 253
2023
Q2 		$2.03M Buy
21,646
+35
+0.2% +$2.73K 0.07% 219
2023
Q1 		$1.47M Buy
21,611
+594
+3% +$38.2K 0.05% 249
2022
Q4 		$1.04M Sell
21,017
-6,609
-24% -$270K 0.04% 282
2022
Q3 		$898K Sell
27,626
-11
-0% -$454 0.03% 297
2022
Q2 		$1.09M Sell
27,637
-11,584
-30% -$619K 0.04% 269
2022
Q1 		$2.74M Sell
39,221
-8,400
-18% -$614K 0.09% 170
2021
Q4 		$3.71M Sell
47,621
-3,378
-7% -$298K 0.11% 152
2021
Q3 		$4.87M Sell
50,999
-125
-0.2% -$13.2K 0.16% 133
2021
Q2 		$6.36M Sell
51,124
-817
-2% -$97.5K 0.21% 113
2021
Q1 		$6.84M Sell
51,941
-1,987
-4% -$272K 0.25% 107
2020
Q4 		$7.14M Buy
53,928
+403
+0.8% +$48.7K 0.26% 98
2020
Q3 		$5.46M Buy
53,525
+2,470
+5% +$213K 0.24% 100
2020
Q2 		$4.44M Sell
51,055
-4,626
-8% -$370K 0.2% 121
2020
Q1 		$3.23M Buy
55,681
+26,801
+93% +$2.18M 0.15% 148
2019
Q4 		$2.67M Sell
28,880
-7
-0% -$615 0.07% 236
2019
Q3 		$2.61M Sell
28,887
-2,175
-7% -$248K 0.07% 261
2019
Q2 		$3.67M Hold
31,062
– – 0.09% 212
2019
Q1 		$2.69M Buy
31,062
+350
+1% +$29.8K 0.07% 284
2018
Q4 		$1.94M Buy
30,712
+14,290
+87% +$981K 0.05% 347
2018
Q3 		$1.3M Buy
16,422
+600
+4% +$39.1K 0.03% 461
2018
Q2 		$946K Buy
15,822
+1,277
+9% +$68.7K 0.02% 503
2018
Q1 		$587K Buy
14,545
+880
+6% +$42.9K 0.02% 595
2017
Q4 		$718K Buy
+13,665
New +$730K 0.02% 541

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Curi RMB Capital's EXAS Position: Q1 2026 in Review

Curi RMB Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 111,021 shares — an estimated $11.3M sold.

Curi RMB Capital first reported a position in EXAS in Q4 2017 and held it in 33 quarters. The position peaked at $11.3M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Curi RMB Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Curi RMB Capital sold 111,021 Exact Sciences shares in Q1 2026, an estimated $11.3M.
  • Curi RMB Capital first reported a position in Exact Sciences in Q4 2017 and held it in 33 quarters.
  • Curi RMB Capital's Exact Sciences position peaked at $11.3M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.